Back to Journals » Pharmacogenomics and Personalized Medicine
Pharmacogenomics and Personalized Medicine
ISSN: 1178-7066
An international, peer-reviewed, open-access journal characterizing the influence of genotype on pharmacology leading to the development of personalized treatment programs and individualized drug selection for improved safety, efficacy and sustainability.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
We are currently seeking expressions of interest for an Associate Editor position and for Editorial Board members for this journal.
Please send your CV and a one-page vision statement detailing your overall objectives for the journal to Emi Kirilova - [email protected]. Please be sure to indicate whether you are interested in the Associate Editor role or a position on the Editorial Board in your application.
Articles:
- View all (636)
- Volume 17, 2024 (15)
- Volume 16, 2023 (97)
- Volume 15, 2022 (82)
- Volume 14, 2021 (155)
- Volume 13, 2020 (72)
- Volume 12, 2019 (34)
- Volume 11, 2018 (24)
- Volume 10, 2017 (31)
- Volume 9, 2016 (14)
- Volume 8, 2015 (16)
- Volume 7, 2014 (37)
- Volume 6, 2013 (15)
- Volume 5, 2012 (12)
- Volume 4, 2011 (10)
- Volume 3, 2010 (11)
- Volume 2, 2009 (9)
- Volume 1, 2008 (2)
Latest articles:
- 5 records -
Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma
Lv L, Zhang X, Liu Y, Zhu X, Pan R, Huang L
Pharmacogenomics and Personalized Medicine 2024, 17:171-181
Published Date: 22 April 2024
ACE Gene Mutations (rs577350502) in Early-Onset and Recurrent Myocardial Infarction: A Case Report and Review
Deng X, Guo X, Chen X, Zeng X, Guo J, Bai X, Zhang P, Wang Y
Pharmacogenomics and Personalized Medicine 2024, 17:163-169
Published Date: 20 April 2024
Identification of a Novel Mitochondrial tRNA Mutation in Chinese Family with Type 2 Diabetes Mellitus
Li X, Shang J, Li S, Wang Y
Pharmacogenomics and Personalized Medicine 2024, 17:149-161
Published Date: 17 April 2024
Downregulation of NAT1 Expression is Associated with Poor Prognosis and Immune Infiltration in COAD
Xu H, Zhang H, Sun S, Zhang J, Huo J, Zhou C
Pharmacogenomics and Personalized Medicine 2024, 17:133-148
Published Date: 16 April 2024
Severe Vincristine-Induced Peripheral Neuropathic Weakness in Both Lower Limbs in an Asian Adolescent with CYP3A4 rs2740574 TT Genotype
Zhang D, Bai J
Pharmacogenomics and Personalized Medicine 2024, 17:125-131
Published Date: 16 April 2024